Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

  • Completed a clinical trial on CRP-guided treatment in febrile primary care patients. This was accompanied by 5 additional publications describing other contextual factors relating to the trial (baseline antibiotic prescription in the sites; social science investigations regarding patient and healthcare worker perspectives on CRP testing)
  • In the process of rolling out a large cluster RCT of CRP testing in Vietnam
  • Produced the first of its kind menu of the costs of AMR per antibiotic drug class for LMICs and high-income settings (Antimicrob Resist Infect Control. 2018;7:98. doi: 10.1186/s13756-018- 0384-3)
  • Cost-effectiveness of interventions to improve hand hygiene in healthcare workers in middle income hospital settings (J Hosp Infect. 2018;100(2):165-75. doi: 10.1016/j.jhin.2018.05.007)
  • Completed first longitudinal study of MDR Klebsiella pneumoniae with whole genome sequencing (Front Microbiol. 2018;9:1197. doi: 10.3389/fmicb.2018.01197)
  • Proof of concept of using machine learning approach to improve antibiotic prescribing in a resource limited hospital setting (Wellcome Open Res. 2018. doi: 10.1101/367037)
  • First RCT evaluation of selective decontamination strategies in high resistance ICU settings (JAMA. 2018;320(20):2087-98. doi: 10.1001/jama.2018.13765)
  • Detailed analysis of transmission dynamics of MDR Enterobacteriaceae in a Cambodian NICU, combining genomic analysis and mathematical modelling, and the first study to quantify the effects of plasmid transfer on ward-level (bioRxiv. 2018; 436006. doi: https://doi. org/10.1101/436006)
  • Major new collaborations established with key US and European networks working on AMR (with CDC funding)
  • New grant for work on adaptive trial designs in emerging epidemics (NIHR 2018-2021)